Use access key #2 to skip to page content.
$15.67 1.22 (8.44%)
11/21/2008 4:01 PM

Pfizer, Inc. (PFE)

CAPS Rating:
****

A research-based, pharmaceutical Company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

View All Commentary (PFE)

Recs

1

Avatar hybridinvestor (88.50) Submitted: 12/08/06 8:47 PM : Outperform Start Price: $22.66 PFE Score: 15.53

The recent drop starts to provide a reasonable entry point for this major pharma player with arguably the deepest pockets in the industry to gobble up smaller players to improve and keep the pipeline full. I would be an aggressive accumulator in the low $20s or below $20.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links